Literature DB >> 19909743

Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome.

Luca Marciani1, Eleanor F Cox, Caroline L Hoad, Susan Pritchard, John J Totman, Steve Foley, Amisha Mistry, Steven Evans, Penny A Gowland, Robin C Spiller.   

Abstract

BACKGROUND & AIMS: Postprandial symptoms are common in patients with irritable bowel syndrome with diarrhea (IBS-D) and could be diet related. We studied postprandial changes in distribution of water in the upper gastrointestinal tract of healthy volunteers (HVs) and patients with IBS-D after contrasting meals.
METHODS: In study 1, 11 HVs consumed 350-mL test meals with 5% mannitol (unabsorbable) or 5% glucose (readily absorbed). In study 2, 17 HVs consumed a 331-kcal meal, with or without 15 g bran. In study 3, 26 patients with IBS-D consumed the study 2 diet with bran meal. All subjects underwent serial magnetic resonance imaging analysis.
RESULTS: In study 1, subjects' small bowel water content (SBWC) increased after the mannitol but not glucose meals, reaching 381 mL (interquartile range, 343-491 mL) and 47 mL (18-78 mL), respectively, 40 minutes after eating (P < .001). In study 2, SBWC initially decreased after both meal types and then increased, plateauing at 180-405 minutes and was greater after the bran meal (P = .02). In study 3, fasting and postprandial SBWC was lower in IBS-D than in HVs (P < .05 and P < .0001, respectively). Patients with IBS-D had faster orocecal transit times (135 minutes; 90-180 minutes) compared with HVs (225 minutes; 203-293 minutes; P < .0001) and reduced terminal ileum diameter (P < .003).
CONCLUSIONS: Postprandial SBWC initially decreases, because of rapid, nutrient-driven fluid absorption, and then increases after a mixed liquid/solid meal. Patients with IBS-D have reduced fasting and postprandial SBWC with faster transit, possibly indicating increased small intestinal tone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909743     DOI: 10.1053/j.gastro.2009.10.055

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  48 in total

1.  Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs.

Authors:  Mary S Kleppe; Kelly M Forney-Stevens; Roy J Haskell; Robin H Bogner
Journal:  AAPS J       Date:  2015-04-08       Impact factor: 4.009

2.  Validation of a rapid, semiautomatic image analysis tool for measurement of gastric accommodation and emptying by magnetic resonance imaging.

Authors:  Sreerup Banerjee; Sudeepa Dixit; Mark Fox; Anupam Pal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-24       Impact factor: 4.052

Review 3.  Small Bowel Motility.

Authors:  Carolina Malagelada; Juan R Malagelada
Journal:  Curr Gastroenterol Rep       Date:  2017-06

Review 4.  Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge.

Authors:  Juan R Malagelada; Anna Accarino; Fernando Azpiroz
Journal:  Am J Gastroenterol       Date:  2017-05-16       Impact factor: 10.864

Review 5.  Recent advances in small bowel diseases: Part I.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

Review 6.  The use of non-narcotic pain medication in pediatric gastroenterology.

Authors:  Adrian Miranda; Miguel Saps
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

7.  Management Strategies for Abdominal Bloating and Distension.

Authors:  Anna Foley; Rebecca Burgell; Jacqueline S Barrett; Peter R Gibson
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-09

Review 8.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

9.  The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.

Authors:  Yasuhiro Tsume; Deanna M Mudie; Peter Langguth; Greg E Amidon; Gordon L Amidon
Journal:  Eur J Pharm Sci       Date:  2014-01-28       Impact factor: 4.384

Review 10.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.